Biotech · Private company · Malvern, PA, US
Spring Mill Pharma Incorporated
Track this companyFree. Adds Spring Mill Pharma Incorporated to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Discovery of novel PBP-targeting chemical warheads to address multidrug-resistant Pseudomonas aeruginosaFiscal year 2026 · $300KNIH RePORTER 1R43AI197818-01 · fetched Nov 12, 2026
- Novel Cyclic Boronate Cell Wall Inhibitors Targeting Carbapenem-Resistant Acinetobacter baumanniiFiscal year 2026 · $1MNIH RePORTER 6R44AI181353-03 · fetched Nov 12, 2026
- Novel cyclic boronate Penicillin Binding Protein Inhibitors to eliminate the threat posed by β-lactamases and enable a future treatment option for carbapenem-resistant Enterobacterales infectionsFiscal year 2025 · $1.1MNIH RePORTER 6R01AI160269-06 · fetched Nov 12, 2026